DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Flinn IW, van der Jagt R, Kahl BS. et al.
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.
Blood 2014;
123: 2944-2952
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.